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Introduction
Carcinoid tumours of the kidney are rare. The first case was reported by Resnick et al 
in 1966.1 A review of the literature shows that 56 cases of primary renal carcinoid have 
been reported2; most of them in Caucasians. To our knowledge, the disease has never 
been reported in a Chinese population although Asian countries, including Japan, have 
reported a few cases. We report our recent experience managing a Chinese woman with 
a carcinoid tumour of the kidney who presented with acute loin pain. All the relevant 
clinical, radiological, operative, and pathological findings are presented.
Case report
A 29-year-old woman with a history of good past health presented in October 2006 with 
a first episode of right loin pain, associated with urinary frequency. Physical examination 
was unremarkable and no abdominal masses were palpable. A computed tomographic 
(CT) scan with contrast showed a 5.8 x 7.7 cm well-circumscribed heterogenous mass at 
the middle and lower poles of the right kidney (Fig 1). The mass had no fat components 
but mild arterial enhancement with enlarged feeding arteries was seen. There was also no 
lymphadenopathy. The overall features suggested a renal cell carcinoma.
 In view of the suspected renal cell carcinoma, a radical nephrectomy was performed 
in early November 2006. At operation, a 9-cm centrally located tumour arising from the 
posterior part of the right kidney near the renal hilum and stretching the hilum anteriorly 
was observed. She recovered well after the operation.
 Macroscopically, the resected kidney (Fig 2a) contained a large, smooth-surfaced, 
haemorrhagic, tan-coloured tumour mass. The tumour measured 8 x 7 x 6 cm. It arose 
from the middle and lower poles of the kidney but protruded into the hilar region and was 
surrounded by a thin capsule. The renal pelvis and proximal ureter were also displaced. 
Histologically, the tumour was separated from the adjacent parenchyma by a well-defined 
thick fibrous capsule. It was composed of cords, ribbons, and tubules of relatively uniform 
cells with little intervening fibrous stroma. The cells were cubo-columnar and medium-
sized with moderate eosinophilic cytoplasm. The nuclei showed minimal variation, and 
were round to oval with coarse chromatin and small nucleoli. Extensive haemorrhage and 
congestion were noted. There was no evidence of vascular invasion and the resection 
margin was clear.
 Because the tumour did not resemble a usual renal carcinoma, immunohistochemical 
studies were performed. It was negative for renal cell marker CD-10 (CALLA), cytokeratin 
CK7 and CK20, pulmonary marker TTF-1, calcitonin and GCDFP. It did show diffuse 
immunoreactivity to CD56 (N-CAM), but was negative for neuroendocrine markers 
chromogranin and synaptophysin. A low proliferative index was illustrated by the 
proliferative marker mib-1. An ultrastructural study showed that most cells possessed 
many membrane-bounded dense core granules ranging in size from 140 to 300 nm (Fig 
2b). These overall features were typical of a renal carcinoid tumour.
 Our patient was followed up regularly after the operation and a CT scan of the 
abdomen and thorax performed 1 year later showed no evidence of secondaries. She 
was also offered an octreotide scan to detect recurrence or metastases but this was not 
carried out for financial reasons. She has never had any symptoms suggestive of carcinoid 
syndrome and her urinary 5-hydroxyindole acetic acid level was within the normal range.
Renal carcinoid tumours are uncommon. The aetiology is not yet fully understood and there 
is still no useful diagnostic tool for detecting them. We report our experience managing a 
Chinese woman with a primary renal carcinoid tumour.
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Discussion
The pathogenesis of renal carcinoid tumours is 
still debatable. Krishnan et al3 reported a frequent 
association with a horseshoe kidney, and related it to 
the presence of teratomatous epithelium. It is believed 
the tumour cells are derived from multipotential 
primitive stem cells capable of neuroendocrine 
differentiation.4,5 Unlike carcinoid disease of other 
organs, renal involvement tends to occur in the 
younger age-group with a mean age of 45.2 years and 
an equal incidence in males and females.6
 In most reported cases, renal carcinoid tumours 
were diagnosed after pathological examination of 
resected specimens that were initially thought to 
be renal cell carcinoma. In symptomatic patients, 
abdominal masses and acute loin pain are the most 
common presenting symptoms. An associated 
carcinoid syndrome is uncommon.2 There are still 
no definite radiological features able to indicate 
the diagnosis before operation. A carcinoid tumour 
is often indistinguishable radiologically from other 
renal tumours such as renal cell carcinomas, making 
it a diagnostic challenge for most clinicians managing 
the disease. Although nuclear medicine scans have 
been used extensively to detect neuroendocrine 
tumours of the gastro-intestinal tract, the drawback 
when evaluating primary renal carcinoid tumours is 
that normal renal uptake of the tracer material may 
obscure the lesion.2 Nevertheless, some authors 
believe it may help to detect residual disease in 
patients who are found to be disease-free by a 
postoperative CT scan.7,8 We usually recommend 
such a scan to our patients as a self-financed item. 
There is still no standard protocol for follow-up of 
patients with renal carcinoid tumours. Measurement 
of hormone production is not useful for making 
the diagnosis as few patients with reported renal 
carcinoid tumours showed an elevation of 5-
hydroxyindole acetic acid.7 Nonetheless, it is a useful 
means of monitoring disease progress.
 Since renal carcinoid tumours have a reported 
metastatic incidence of approximately 25.7%,6 most 
surgeons believe radical nephrectomy should be 
offered. The size of the tumour reportedly correlates 
well with the incidence of metastasis.9 The most 
common sites for metastasis are the prehilar lymph 
nodes and liver, followed by the bones and lungs.2 
Radiolabelled somatostatin analogues are being 
used by endocrine surgeons to manage metastatic 
unresectable neuroendocrine tumours although 
no conclusion about their effectiveness has been 
reached. In general, the prognosis is good for renal 
carcinoid tumours, with reported survival rates 
reaching 88.6%.6
 Renal carcinoid tumours are uncommon 
in the Chinese population. This case illustrates 
management of a renal mass with special reference 
to renal carcinoid tumours. Although it is difficult 
to diagnose this disease without an operation, it is 
potentially curable and regular follow-up is important 
for detecting metastases if present.
FIG 1. Computed tomographic scan of the abdomen showing 
the lesion before operation
FIG 2. (a) Macroscopic and (b) ultrastructural views of the resected specimen
(a) (b)
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